"{\n    \"Title\": \"Notes to Consolidated Financial Statements\",\n    \"row 1\": \"March 31, 2020\",\n    \"row 2\": \"13. Financial Instrument Fair Value Measurement\",\n    \"row 3\": \"The following table provides an analysis of financial instruments that are measured subsequent\",\n    \"row 4\": \"to initial recognition at fair value, grouped into levels 1, 2 and 3 based on the degree to which\",\n    \"row 5\": \"the fair value is observable:\",\n    \"row 6\": \"e Level 1 fair value measurements are those derived from quoted prices (unadjusted) in\",\n    \"row 7\": \"active markets for identical assets or liabilities using the last bid price;\",\n    \"row 8\": \"e Level 2 fair value measurements are those derived from inputs other than quoted prices\",\n    \"row 9\": \"included within Level 1 that are observable for the asset or liability either directly (i.e.\",\n    \"row 10\": \"as prices) or indirectly (i.e. derived from prices); and\",\n    \"row 11\": \"e Level 3 fair value measurements are those derived from valuation techniques that\",\n    \"row 12\": \"include inputs for the asset or liability that are not based on observable market date\",\n    \"row 13\": \"(unobservable inputs).\",\n    \"row 14\": \"2020\",\n    \"row 15\": \"Level 1 Level 2 Level 3 Total\",\n    \"row 16\": \"Caldwell infant trusts\",\n    \"row 17\": \"payable S$ 439,405 \\u00a7 - \\u00a7 - \\u00a7 439,405\",\n    \"row 18\": \"2019\",\n    \"row 19\": \"Level 1 Level 2 Level 3 Total\",\n    \"row 20\": \"Caldwell infant trusts\",\n    \"row 21\": \"payable S 274,405 \\u00a7$ - \\u00a7 - \\u00a7 274,405\",\n    \"row 22\": \"Long-term\",\n    \"row 23\": \"investments 4,159,935 - - 4,159,935\",\n    \"row 24\": \"S 4,434,340 $ - \\u00a7 - \\u00a7 4,434,340\",\n    \"row 25\": \"There were no transfers between Level 1 and Level 2 for the year ended March 31, 2020. There\",\n    \"row 26\": \"were also no transfers in or out of Level 3.\"\n}"